Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma

PHASE2UnknownINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2013

Conditions
Mantle Cell Lymphoma
Interventions
DRUG

bortezomib

Given IV

Trial Locations (48)

11030

CCOP - North Shore University Hospital, Manhasset

Don Monti Comprehensive Cancer Center at North Shore University Hospital, Manhasset

11040

Long Island Jewish Medical Center, New Hyde Park

11042

Monter Cancer Center of the North Shore-LIJ Health System, Lake Success

13210

SUNY Upstate Medical University Hospital, Syracuse

61350

Community Hospital of Ottawa, Ottawa

Oncology Hematology Associates of Central Illinois, PC - Ottawa, Ottawa

61354

Illinois CancerCare - Peru, Peru

Illinois Valley Community Hospital, Peru

61356

Illinois CancerCare - Princeton, Princeton

Perry Memorial Hospital, Princeton

61362

Illinois CancerCare - Spring Valley, Spring Valley

61401

Galesburg Clinic, PC, Galesburg

Illinois CancerCare - Galesburg, Galesburg

61443

Illinois CancerCare - Kewanee Clinic, Kewanee

61455

Illinois CancerCare - Macomb, Macomb

McDonough District Hospital, Macomb

61462

Illinois CancerCare - Monmouth, Monmouth

OSF Holy Family Medical Center, Monmouth

61520

Graham Hospital, Canton

Illinois CancerCare - Canton, Canton

61530

Eureka Community Hospital, Eureka

Illinois CancerCare - Eureka, Eureka

61603

Illinois CancerCare - Pekin, Pekin

61614

Proctor Hospital, Peoria

61615

CCOP - Illinois Oncology Research Association, Peoria

Oncology Hematology Associates of Central Illinois, PC - Peoria, Peoria

61636

Methodist Medical Center of Illinois, Peoria

61637

OSF St. Francis Medical Center, Peoria

61701

Illinois CancerCare - Bloomington, Bloomington

St. Joseph Medical Center, Bloomington

61761

BroMenn Regional Medical Center, Normal

Community Cancer Center, Normal

Illinois CancerCare - Community Cancer Center, Normal

62321

Illinois CancerCare - Carthage, Carthage

Memorial Hospital, Carthage

62644

Illinois CancerCare - Havana, Havana

Mason District Hospital, Havana

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

60637-1470

University of Chicago Cancer Research Center, Chicago

02115

Dana-Farber/Brigham and Women's Cancer Center, Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

03756-0002

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

43210-1240

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00310037 - Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | Biotech Hunter | Biotech Hunter